Table 1 Expression intensities of studied markers grouped and encoded according to established assessment scales
Number of cases (% of cases) | ||||||
|---|---|---|---|---|---|---|
Expression intensity | Non-metastatic MMP-2 | Metastatic MMP-2 | Non-metastatic E-cad | Metastatic E-cad | Non-metastatic Ki-67 | Metastatic Ki-67 |
None | 3 (15.0) | 0 (0.0) | 3 (15.0) | 4 (33.3) | 7 (35.0) | 1 (8.4) |
Weak | 9 (45.0) | 6 (50.0) | 8 (40.0) | 2 (16.7) | 6 (30.0) | 6 (50.0) |
Moderate | 5 (25.0) | 5 (41.6) | 2 (10.0) | 3 (25.0) | 6 (30.0) | 3 (25.0) |
Intense | 3 (15.0) | 1 (8.4) | 7 (35.0) | 3 (25.0) | 1 (5.0) | 2 (16.4) |